Company · CIK 1604477

# SQZ Biotechnologies Co

| CIK | [1604477](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001604477) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-12-10 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-260980 | Shelf Effective | 2021-11-12 | 2023-12-01 | 3 |
| 333-252889 | Registered company Final prospectus | 2021-02-09 | 2021-02-12 | 3 |
| 333-249422 | IPO Final prospectus | 2020-10-09 | 2020-10-30 | 4 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-12-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1604477/999999999523003512/9999999995-23-003512-index.htm) Declared effective | 333-260980 | 9999999995-23-003512 |
| 2021-11-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1604477/999999999521004408/9999999995-21-004408-index.htm) Declared effective | 333-260980 | 9999999995-21-004408 |
| 2021-11-12 | [S-3](https://www.sec.gov/Archives/edgar/data/1604477/000119312521326292/0001193125-21-326292-index.htm) Shelf registered | 333-260980 | 0001193125-21-326292 |
| 2021-02-12 | [424B4](https://www.sec.gov/Archives/edgar/data/1604477/000119312521041850/0001193125-21-041850-index.htm) Final prospectus | 333-252889 | 0001193125-21-041850 |
| 2021-02-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1604477/999999999521000623/9999999995-21-000623-index.htm) Declared effective | 333-252889 | 9999999995-21-000623 |
| 2021-02-09 | [S-1](https://www.sec.gov/Archives/edgar/data/1604477/000119312521034349/0001193125-21-034349-index.htm) Registration filed | 333-252889 | 0001193125-21-034349 |
| 2021-02-01 | [DRS](https://www.sec.gov/Archives/edgar/data/1604477/000095012321000774/0000950123-21-000774-index.htm) Draft made public | 377-04140 | 0000950123-21-000774 |
| 2020-10-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1604477/000119312520282707/0001193125-20-282707-index.htm) Final prospectus | 333-249422 | 0001193125-20-282707 |
| 2020-10-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1604477/999999999520003031/9999999995-20-003031-index.htm) Declared effective | 333-249422 | 9999999995-20-003031 |
| 2020-10-26 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1604477/000119312520276011/0001193125-20-276011-index.htm) Amendment | 333-249422 | 0001193125-20-276011 |
| 2020-10-09 | [S-1](https://www.sec.gov/Archives/edgar/data/1604477/000119312520267294/0001193125-20-267294-index.htm) Registration filed | 333-249422 | 0001193125-20-267294 |
| 2020-07-21 | [DRS](https://www.sec.gov/Archives/edgar/data/1604477/000095012320007066/0000950123-20-007066-index.htm) Draft made public | 377-03317 | 0000950123-20-007066 |

[All filings of this company](https://equitycapital.markets/filings?cik=1604477) · [CSV](https://equitycapital.markets/filings.csv?cik=1604477)

---
Source page: https://equitycapital.markets/company/1604477 · Data: U.S. SEC EDGAR · CC BY 4.0